Measurement of peri-prostatic fat thickness using transrectal ultrasonography (TRUS): A new risk factor for prostate cancer

BJU International

Volumn 110, Issue 7, 2012, Pages 980-986

  Bhindi, Bimal ^a   Trottier, Greg ^a   Elharram, Malik ^b   Fernandes, Kimberly A ^b   Lockwood, Gina ^c   Toi, Ants ^d   Hersey, Karen M ^a   Finelli, Antonio ^a   Evans, Andrew ^d   Van Der Kwast, Theodorus H ^d   Fleshner, Neil E ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Canadian Partnership Against Cancer   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

peri prostatic fat; prostate cancer; transrectal ultrasonography (TRUS)

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FAT MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPROSTATIC FAT THICKNESS; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT; RISK FACTOR; TRANSRECTAL ULTRASONOGRAPHY; ADIPOSE TISSUE; ECHOGRAPHY; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; PROSTATE; PROSTATE TUMOR; RETROSPECTIVE STUDY; ULTRASTRUCTURE;

ADIPOSE TISSUE; AGED; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; ULTRASONOGRAPHY;

EID: 84871694322     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.10957.x     Document Type: Article

References (26)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR,. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-41
2. Tjepkema M,. Adult obesity in Canada: measured height and weight. Statistics Canada website. Available at: http://www.statcan.gc.ca/pub/82-620-m/ 2005001/article/adults-adultes/8060-eng.htm. Accessed January, 2012.
3. Donohoe CL, Pidgeon GP, Lysaght J, Reynolds JV,. Obesity and gastrointestinal cancer. Br J Surg 2010; 97: 628-42
4. Kitahara CM, Platz EA, Freeman LE, et al,. Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of 5 prospective studies. Cancer Epidemiol Biomarkers Prev 2011; 20: 464-72
5. Hankin JH, Rawlings V,. Diet and breast cancer: a review. Am J Clin Nutr 1978; 31: 2005-16
6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ,. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-38
7. Porter MR, Stanford JL,. Obesity and the risk of prostate cancer. Prostate 2005; 62: 316-21
8. Giovannucci E, Rimm EB, Liu Y, et al,. Body Mass Index and Risk of Prostate Cancer in U.S. Health Professionals. J Natl Cancer Inst 2003; 95: 1240-4
9. Svartberg J, von Muhlen D, Sundsfjord J, Jorde R,. Waist circumference and testosterone levels in community dwelling men. The Tromsø study. Eur J Epidemiol 2004; 19: 657-63
10. Baillargeon J, Pollock BH, Kristal AR, et al,. The association between body mass index and prostate-specific antigen in a population-based study. Cancer 2005; 103: 1092-5
11. Klein EA, Platz EA, Thompson IM,. Epidemiology, etiology, and prevention of prostate cancer. In, Wein AJ, Kassouvi LR, Novick AC, Partin AW, Peters CA, eds, Campbell-Walsh Urology, 9th edn. Philadelphia: Saunders Elsevier, 2007: 2854-73
12. Freedland SJ, Wen J, Wuerstle M, et al,. Obesity Is a Significant Risk Factor for Prostate Cancer at the Time of Biopsy. J Urol 2008; 72: 1102-5
13. Freedland SJ, Aronson WJ, Kane CJ, et al,. Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group. J Clin Oncol 2004; 22: 446-53
14. Freedland SJ, Banez LL, Sun LL, Fitzsimons NJ, Moul JW,. Obese men have higher-grade and larger tumors: an analysis of the Duke prostate center database. Prostate Cancer Prostatic Dis 2009; 12: 259-63
15. MacInnis RJ, English DR,. Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 2006; 17: 989-1003
16. Cao Y, Ma J,. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev Res 2011; 4: 486-501
17. Karastergiou K, Mohamed-Ali V,. The autocrine and paracrine roles of adipokines. Mol Cell Endocrinol 2010; 318: 69-78
18. Rabe K, Lehrke M, Parhofer KG, Broedl UC,. Adipokines and insulin resistance. Mol Med 2008; 14: 741-51
19. Finley DS, Calvert VS, Inokuchi J, et al,. Periprostatic adipose tissue as a modulator of prostate cancer aggressiveness. J Urol 2009; 182: 1621-7
20. Culig Z, Steiner H, Bartsch G, Hobisch A,. Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 2005; 95: 497-505
21. Schafer ZT, Brugge JS,. IL-6 involvement in epithelial cancers. J Clin Invest 2007; 117: 3660-3
22. Van Roermund JG, Hinnen KA, Tolman CJ, et al,. Periprostatic fat correlates with tumour aggressiveness in prostate cancer patients. BJU Int 2011; 107: 1775-9
23. Babaian RJ, Toi A, Kamoi K, et al,. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 2000; 163: 152-7
24. Van Roermund JG, Bol GH, Witjes JA, Ruud Bosch JL, Kiemeney LA, van Vulpen M,. Periprostatic fat measured on computed tomography as a marker for prostate cancer aggressiveness. World J Urol 2010; 28: 699-704
25. Toi A, Neill MG, Lockwood GA, Sweet JM, Tammsalu LA, Fleshner NE,. The continuing importance of transrectal ultrasound identification of prostatic lesions. J Urol 2007; 177: 516-20
26. Nam RK, Saskin R, Lee Y, et al,. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 963-8